Corteva Sees Unusually Large Options Volume (NYSE:CTVA)

Corteva, Inc. (NYSE:CTVA) was the target of some unusual options trading on Thursday. Stock traders purchased 2,661 call options on the company. This is an increase of approximately 149% compared to the average volume of 1,070 call options.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CTVA shares. Oppenheimer set a $17.00 price target on Corteva in a report on Monday, October 5th. Zacks Research lowered shares of Corteva from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 6th. UBS Group dropped their price objective on shares of Corteva to $15.00 and set a “neutral” rating on the stock in a research note on Monday, October 12th. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Finally, Deutsche Bank restated a “buy” rating and issued a $101.00 target price on shares of Corteva in a research note on Monday, August 3rd. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $60.59.

Institutional Investors Weigh In On Corteva

A number of institutional investors and hedge funds have recently bought and sold shares of CTVA. BlackRock Inc. purchased a new stake in shares of Corteva in the second quarter valued at $4,560,180,000. Wellington Management Group LLP raised its stake in Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares during the last quarter. Jupiter Topco LLC purchased a new position in Corteva in the 2nd quarter valued at about $544,246,000. Bank of America Corp DE purchased a new position in Corteva in the 2nd quarter valued at about $484,927,000. Finally, Legal & General Group Plc acquired a new stake in shares of Corteva during the 2nd quarter worth about $482,836,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Recent Corteva Headlines

Investors following CTVA have been watching these headlines:

• Positive Sentiment: Corteva reported third-quarter adjusted EPS of $0.06, above the $0.02 consensus, and revenue of $2.46 billion versus analysts’ $1.77 billion estimate. The company also cited growth in new-product sales and continued operational execution, although revenue was down 8.7% year over year. Corteva third-quarter results and outlook
• Neutral Sentiment: Call-option trading was unusually active, with 2,661 calls purchased—149% above the average volume. This may indicate bullish speculative positioning, but options activity alone does not establish a change in the company’s outlook.
• Neutral Sentiment: Corteva delayed its quarterly report following the seed-business spin-off. The report does not specify whether the delay will have a material financial or operational effect. Corteva delays quarterly report

Corteva Stock Performance

Shares of CTVA stock traded down $2.96 during trading hours on Thursday, reaching $9.18. 15,681,336 shares of the company’s stock were exchanged, compared to its average volume of 8,050,942. The company has a market cap of $6.12 billion, a P/E ratio of 6.08, a price-to-earnings-growth ratio of 1.70 and a beta of 0.58. The company’s 50 day moving average is $40.43 and its two-hundred day moving average is $70.20. Corteva has a 1 year low of $9.17 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, November 12th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.04. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The firm had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the previous year, the business earned ($0.23) earnings per share. The company’s revenue for the quarter was down 8.7% compared to the same quarter last year. Equities research analysts anticipate that Corteva will post 1.05 EPS for the current fiscal year.

Corteva Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, December 1st. This is a decrease from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 dividend on an annualized basis and a yield of 2.2%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.